Navigation Links
NutraCea Announces Third Quarter 2008 Financial Results
Date:11/7/2008

PHOENIX, Nov. 7 /PRNewswire-FirstCall/ -- NutraCea (OTC Bulletin Board: NTRZ), a world leader in stabilized rice bran (SRB) nutrient research and technology, today announced financial results for its third quarter ended September 30, 2008.

Net revenues for the 2008 third quarter increased to $11.2 million compared with net revenues of $1.5 million for the third quarter of 2007. Growth was driven by a $1.9 million increase in net revenues from the Company's NutraCea segment and $7.8 million from its Irgovel subsidiary which was acquired in 2008. Net revenues for the third quarter of 2007 were offset by $1.5 million of returned product.

Sequentially, net revenues for the third quarter of 2008 increased 8.6% over second quarter 2008 net revenues of $10.3 million. The Company's two business segments, NutraCea and Irgovel, recorded net revenues of $3.4 million and $7.8 million, respectively, for third quarter of 2008.

Net loss for the third quarter of 2008 decreased to $4.5 million, or ($0.03) per share, compared to a net loss of $4.8 million or ($0.03) per share, in the comparable period of 2007. The decreased net loss for the 2008 third quarter was primarily due to the increased gross margin of $2.6 million, offset by a net increase of $2.4 million in operating expenses, other expenses and income, and income taxes.

Sequentially, NutraCea realized a reduction in net loss from the $6.1 loss reported in the second quarter of 2008 compared with the $4.5 million net loss reported in the third quarter of 2008. Our NutraCea segment had a loss before income taxes of $5.0 million compared with a net loss before income taxes of $6.9 million in the second quarter of 2008. The Irgovel segment, which was acquired in February 2008, reported income before income taxes of $718,000 for third quarter of 2008.

Sales, General and Administrative (SG&A) expenses totaled $6.5 million for the third quarter of 2008, compared with SG&A expenses of $4.6
'/>"/>

SOURCE NutraCea
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. NutraCea Announces Third Quarter 2008 Conference Call
2. Mike Bridges Takes Home Four Gold Medals at IPF Masters World Powerlifting Championships; Says NutraCeas RiSolubles(R) is an Essential Part of his Training Regimen
3. U.S. Chamber Recognizes NutraCea for Strong Corporate Stewardship
4. NutraCea Announces First Quarter 2008 Financial Results
5. NutraCea to Host First Quarter 2008 Conference Call on May 12.
6. NutraCea Announces $20 Million Securities Offering
7. Demand for NutraCea Rice Bran Oil Prompts Major Expansion of Irgovel Plant Ahead of Schedule
8. NutraCea-Sponsored Study Demonstrates Benefits of Replacing Wheat Flour with Stabilized Rice Bran (SRB) in Battered and Fried Product Applications
9. NutraCea Appoints New Chief Financial Officer
10. New World Record Holder in Powerlifting Credits NutraCeas Unique Rice-Bran-derived Product as his Secret Weapon
11. NutraCea to Purchase Largest Rice Bran Oil Processing Facility in South America

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... arsenic compounds appears to cause oxidative DNA ...rding to a new study published online November 23 ... , Although biomethylation was once believed to ...nhance its toxicity and potentially its carcinogen...ylation in oxidative DNA damage in mice, Michael P...
(Date:11/23/2009)...ir odds drop by 63 percent with moderate-to-high i...ealthDay News) -- Moderate-to-high intensity exerc...educe stroke risk in older men but not in women, r...3,300 men and women, average age 69, in Manhattan ...t time, there were 238 strokes among the participa...
(Date:11/23/2009)...pswithMinorityBanksin Washington D.C. , NewY...tendedtoSpurEconomicGrowthandRevitalization ,,...ita,thenation,sleadingproviderofdialysisservices,t...iacommunityfora$1millioninvestmentinIndustrialBank...unities. ,, DaVita,sinvestmentinWashington,D.C....
(Date:11/23/2009)...23/PRNewswire/-- ,, WHAT: ,, TheBerylInst...nies, thenation,sleadinghealthcareexclusivecallce...chconsumersineverygenerationwithapositivecustomers...nuteClinic,thisWebinarwillsupplementHowe,sJune2009...ctive,"whichdiscusseshowconsumerswillultimatelytra...
(Date:11/23/2009)....23/PRNewswire/--Howistheeconomyaffectingpeople,sw...iWellnessonWellness&theEconomy,theeconomyismak...ealthylifestyleofexerciseanddiettoonethatismoreinw..., Thesurvey,smostdramaticfindingwasthechangeincon...tionalfocusonhealthandwellbeingtotoday,smorereleva...
Breaking Medicine News(10 mins):Health News:Vigorous Exercise Cuts Stroke Risk for Men, Not Women 2Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 2Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 3Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 4Health News:Tips to Improve Healthcare Customer Service Across All Generations 2Health News:Being Well Is About Reinvention - Not Health 2Health News:Being Well Is About Reinvention - Not Health 3
...e replacement are becoming the order of the day, o...e John Flynn Hospital, Gold Coast, Brisbane, Austr...king to the medical fraternity while demonstrating...emonstration and a workshop on the technology mark...
...sans glamorous clothes, high heels and choreograph...t women's contest with the aim of reducing infant ...competition evaluates mothers' weights during preg...om nearby hospitals, NGO members working in the sl...
...r OxyContin agreed to pay $600 million in fines an... misbranding the product , one of the largest amou... Three of its current and former executives plea... narcotics. The three executives, including i...
...oyed, for her upcoming tour bosses have asked her ...ll the gig is over . According to a source... another baby soon, she was bugged by the contract...was narked that she was the only one approached ab...
...Lohan got back to her boozing ways while still und... The actress guzzled vodka and Red Bull ener...ises rehab. Following the incident, furiou...izza. However, she was secretly pouring vodka into...
...e adverse effects of the simultaneous use of presc...e being under-reported, and that health-care profe...e potential risks of combining the two therapies. ...ey had encountered a patient with a suspected adve...
Other Medicine News:Health News:Hip and Knee Replacements Becoming More Patient-friendly 2Health News:Hip and Knee Replacements Becoming More Patient-friendly 3Health News:Pregnant Women's Contest to Curb Infant Mortality 2Health News:Purdue Pharma Agrees to Pay $600 Million Fine for Misbranding Oxycontin 2Health News:Purdue Pharma Agrees to Pay $600 Million Fine for Misbranding Oxycontin 3Health News:Purdue Pharma Agrees to Pay $600 Million Fine for Misbranding Oxycontin 4Health News:Side Effects of Natural Health Products With Prescription Drugs Under-reported 2
(Date:11/23/2009)...e/--Reportlinker.comannouncesthatanewmarketresearc...itoringSystems-AGlobalMarketReview ,, http:/...ystems---A-Global-Market-Review.html#utm_source=pr...wire ,, Cardiovascularmonitoringisextremely...tobecontinuouslymonitoredduringdiagnosticaswellasp...
(Date:11/23/2009)...Newswire/--LightSciencesOncology,Inc.(LSO)todayann...,Elekta,toanewlycreatedseatonitsboardofdirectors.M...oductcompanies,includingElekta,tomarketleadership....alstrengthinbusinessdevelopmenttotheboard,"saidLSO...dleaderincancer-therapybusinessdevelopment.Hehasov...
(Date:11/23/2009).../PRNewswire/--Sarnova,Inc.,thenation,sleadingspeci...edicalservices(EMS)andrespiratorymarkets,announced...nagementteam.ThenewexecutivesincludeTomDavid,execu...esidentandgeneralcounsel;SteveLacke,executivevicep...epresidentofcorporatedevelopment. ,, "Ihavework...
Breaking Medicine Technology:Reportlinker Adds Holter Monitoring Systems - A Global Market Review 2Reportlinker Adds Holter Monitoring Systems - A Global Market Review 3Reportlinker Adds Holter Monitoring Systems - A Global Market Review 4Reportlinker Adds Holter Monitoring Systems - A Global Market Review 5Light Sciences Oncology Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors 2Sarnova Expands Senior Management Team 2GHXcellence Awards Honor Healthcare Providers and Suppliers for Achievements in Supply Chain Performance 47930 1GHXcellence Awards Honor Healthcare Providers and Suppliers for Achievements in Supply Chain Performance 47930 2GHXcellence Awards Honor Healthcare Providers and Suppliers for Achievements in Supply Chain Performance 47930 3Weber Shandwick Chosen By National Marrow Donor Program 28R 29 To Head Awareness Campaign 47925 1Weber Shandwick Chosen By National Marrow Donor Program 28R 29 To Head Awareness Campaign 47925 2Weber Shandwick Chosen By National Marrow Donor Program 28R 29 To Head Awareness Campaign 47925 3MD On Line Inc Acquires Medical Claim Corp 47920 1MD On Line Inc Acquires Medical Claim Corp 47920 2
...ATEO, Calif., July 11 NeurogesX, Inc.,(Nasdaq: N...loping and,commercializing novel pain management t...clinical trial (study C203) of NGX-1998. The produ...sed liquid formulation,designed to deliver a local... The randomized, single-blind Phase 1 trial is des...
...ETON, N.J., July 10 Medarex, Inc.,(Nasdaq: MEDX ...y,s,strategy, strength in research discovery and a...s Medarex is engaged in for creating long-term val...and future antibody programs,as well as updated 20...President and CEO, Howard H. Pien, and other membe...
Other Medicine Technology:NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation 2NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation 3NeurogesX Initiates Dosing in Phase 1 Clinical Trial for NGX-1998 Capsaicin Liquid Formulation 4Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City 2Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City 3Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City 4Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City 5Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City 6
XT-1800i
SF-3000
Coulter AcT 5diff OV
XE-2100L
Medicine Products: